Director of Adult Survivorship, Associate Professor of Medicine
Dana-Farber Cancer Institute, Harvard Medical School
Alicia Morgans, MD, MPH, is a Genitourinary Medical Oncologist, Director of the Adult Survivorship Program at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School. A clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making.
Dr. Morgans received her MD degree from the University of Pennsylvania School of Medicine in 2006 and her Master of Public Health (MPH) degree from Vanderbilt University School of Medicine in 2015.
Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications. Her work has been funded by grants from the National Comprehensive Cancer Network, the Prostate Cancer Foundation, and the Department of Defense. She leads multiple therapeutic and quality-of-life focused clinical trials for prostate cancer patients.
She is a member of the advanced and localized prostate cancer treatment guidelines committee of the American Urologic Association and a member of the cardio-oncology committee of the American Heart Association.